Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Neurogastroenterology and Motility|April 23, 2014
The role of pain modulators in esophageal disorders - no pain no gainR Dickman, C Maradey-Romero, R FassNeurogastroenterology and Motility|August 31, 2007
Assessment of 24-h oesophageal pH monitoring should be divided to awake and asleep rather than upright and supine time periodsR Dickman, M Shapiro, I B Malagon, et al.Alimentary Pharmacology & Therapeutics|September 19, 2007
Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburnR Dickman, E Schiff, A Holland, et al.Alimentary Pharmacology & Therapeutics|September 20, 2005
The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trialR Dickman, S Emmons, H Cui, et al.Alimentary Pharmacology & Therapeutics|June 9, 2007
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groupsR Dickman, S Parthasarathy, I B Malagon, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 21, 2006
Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagusR Dickman, J L Kim, L Camargo, et al.Alimentary Pharmacology & Therapeutics|February 1, 2005
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trialW-M Wong, J Bautista, R Dekel, et al.Zeitschrift Fur Gastroenterologie|November 21, 2007
Non-erosive reflux disease (NERD) and erosive esophagitis--a spectrum of disease or special entities?R FassDigestive Diseases (Basel, Switzerland)|March 24, 2000
Empirical trials in treatment of gastroesophageal reflux diseaseR FassPageof 26